Alzheimer's clinical trial launched

Published date : 08 August 2012
Article date : 08 August 2012

Researchers in the U.S. and Canada launched a clinical trial to evaluate deep-brain stimulation in the treatment of mild Alzheimer's disease. The study will engage 20 people, aged 55-80, with Medtronic's deep brain stimulation technology - surgically implanted devices similar to a cardiac pacemaker and that deliver electrical pulses to targeted areas of the brain.  

The trial, conducted by Functional Neuromodulation Ltd., will use Medtronic's DBS therapy to target a specific area considered a "major inflow and output pathway in the brain's memory circuit."
Each patient in the study will receive the implant. Researchers will compare the effects of the implant turned on and turned off at random for a follow-up period of 12 months. Thereafter, patients with the device turned off may opt to activate their implants.
Read the full article here


Back to Listings

WhichMedicalDevice is a FREE resource created by clinicians for clinicians.

Registration is free and gives you unlimited access to all of the content and features of this website.

Find out more...

Please sign in to view this content...

I have forgotten my password
Not a Member?

Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...

Why Register

Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.

We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.